查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
人类微生物组市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按类型、应用、疾病类型和地理位置
市场调查报告书
商品编码
1624226

人类微生物组市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围：按类型、应用、疾病类型和地理位置

Human Microbiome Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Disease Type, and Geography
出版日期: | 出版商: The Insight Partners | 英文 174 Pages | 订单完成后即时交付

价格

人类微生物组市场预计将从 2023 年的 10.7 亿美元增至 2031 年的 48.4 亿美元；预计 2023 年至 2031 年市场复合年增长率为 20.8%。推动市场成长的主要因素是主要市场参与者和政府措施的重大投资。此外，精准医疗的出现可能会在预测期内提振市场。然而，商业化过程中的挑战是市场阻碍因素之一。

人类微生物组产业的成长、创新和市场动态很大程度上受到市场主要参与者的投资影响。主要参与者都在研发方面进行了大量投资，以创造基于微生物组的新型益生菌、诊断和治疗方法。这些支出刺激创新，辨识新菌株、作用模式和医药用途。临床试验获得大量资金，这对于证明基于微生物组的产品的有效性和安全性至关重要。微生物组图谱技术的先驱Kanvas Biosciences 于2023 年6 月宣布获得1,200 万美元的Pre-A 轮融资。的发展。这些合作伙伴关係使资源、专业知识和技术进步的共享变得更加容易，从而加快了产品开发速度。例如，全球最大的食品和饮料公司雀巢与顶级 SFI 研究中心 APC Microbiome Ireland 于 2023 年 7 月宣布了一项新的合作。增强人类健康和福祉的产品。据报道，多达 120 家公司正在投资微生物组分析，许多新创公司正在进入该领域。 Flagship Pioneering、Seventure Partners 和 BioGaia 是最活跃的投资者。因此，主要参与者的投资增加可能会推动市场的成长。

比较公司分析根据产品组合（产品满意度、产品功能和可用性）、近期市场发展（併购、新产品推出和增强、投资和融资、奖励、协议、合作、和合作伙伴关係、认可和扩张）以及有助于更好决策和了解竞争格局的地理分布。该报告深入探讨了全球人类微生物组市场领先供应商近期的重大发展和创新。主要市场参与者为 MaaT Pharma；辉凌控股有限公司；芬奇治疗集团公司； AOBiome 治疗公司；塞雷斯治疗公司；默克公司；养乐多本社有限公司；瑞必泰克斯；公司； IFF 营养与生物科学；和合成生物製剂公司

人类微生物组市场依类型分为产品、软体和服务。 2023年，该产品领域在人类微生物组市场中占据更大份额，预计2023-2031年期间复合年增长率将更高。人体微生物组包括人体内部和表面的所有微生物。这些微生物具有用于疾病管理的潜力。微生物组产品在治疗严重疾病和个人化治疗方面显示出前景。微生物群与神经系统疾病、发炎性疾病和癌症有关。

根据应用，市场分为治疗、诊断和研究。到2023 年，治疗领域将占据人类微生物组市场的最大份额。性。近年来，基于微生物组的疗法，也称为微生物组调节剂，取得了快速进展。一些有前途的候选人已经透过临床管道取得进展。例如，2023 年4 月，Ferring Pharmaceuticals 的VOWST 是第一个口服的粪便微生物产品，被批准用于预防18 岁及以上患者在接受抗生素治疗復发性感染后艰难梭菌(C. difficile) 感染的复发。

根据疾病类型，人类微生物组市场分为肥胖、糖尿病、自体免疫疾病、癌症、胃肠道疾病等。 2023 年，胃肠道疾病细分市场在人类微生物组市场中占据最大份额。

人类微生物组市场的公司采用了各种有机和无机策略。有机策略主要包括产品发布和产品批准。市场上常见的无机成长策略包括收购、合作和伙伴关係。这些成长策略使市场参与者能够扩大业务并增强其地理影响力，同时为整体市场成长做出贡献。此外，收购和合作等策略有助于加强他们的客户群并扩展他们的产品组合。以下列出了人类微生物组市场主要参与者的一些重大进展。

2024 年 3 月，MaaT Pharma 宣布在欧洲启动一项名为 CHRONOS 的回顾性多中心试验。其目标是为未接受 MaaT013 或任何微生物组干预的患者提供三线疗法的公司疗效资料。这项研究并未受到监管机构的要求，也不会影响现金预测，因为资金已经到位。

2021 年7 月，Seres Therapeutics, Inc. 和雀巢健康科学签订了商业化许可协议，共同将Seres 的用于治疗復发性艰难梭菌感染(CDI) 的口腔微生物组治疗药物SER-109 在美国和加拿大商业化。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第 4 章：人类微生物组市场格局

  • 概述
  • PEST分析

第 5 章：人类微生物组市场 - 主要市场动态

  • 人类微生物组市场 - 主要市场动态
  • 市场驱动因素
    • 主要市场参与者的重大投资
    • 政府倡议
  • 市场限制
    • 商业化过程中的挑战
  • 市场机会
    • 研发方面的强劲投资
  • 未来趋势
    • 精准医学的出现
  • 驱动因素和限制的影响：

第 6 章：人类微生物组市场 - 全球市场分析

  • 人类微生物组市场收入，2021-2031
  • 人类微生物组市场预测分析

第 7 章：人类微生物组市场分析 - 按类型

  • 产品
  • 软体和服务

第 8 章：人类微生物组市场分析 - 按应用

  • 疗法
  • 诊断
  • 研究

第 9 章：人类微生物组市场分析 - 按疾病类型

  • 肥胖
  • 糖尿病
  • 自体免疫疾病
  • 癌症
  • 胃肠道
  • 其他的

第 10 章：人类微生物组市场 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：竞争格局

  • 概述
  • 人类微生物组市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • MaaT Pharma
  • Ferring Holdings SA
  • AOBiome Therapeutics Inc
  • Finch Therapeutics Group Inc
  • Seres Therapeutics Inc
  • Merck & Co Inc
  • Yakult Honsha Co., Ltd.
  • Rebiotix, Inc.
  • IFF Nutrition & Biosciences
  • Synthetic Biologics, Inc.

第 13 章：附录

Product Code: TIPBT00002233

The human microbiome market is expected to reach US$ 4.84 billion by 2031 from US$ 1.07 billion in 2023; the market is estimated to register a CAGR of 20.8% during 2023-2031. Major factors driving the market growth significant investments by key market players and government initiatives. Further, the emergence of precision medicine is likely to boost the market during the forecast period. However, challenges during commercialization are among the market deterrents.

The human microbiome industry's growth, innovation, and market dynamics are greatly influenced by the investments made by major players in the market. Major players are engaged in making significant investments in research and development to create novel probiotics, diagnostics, and treatments based on the microbiome. These expenditures stimulate innovation, identifying new strains, modes of action, and medicinal uses. Clinical trials receive a large amount of funding, which is essential for demonstrating the effectiveness and safety of products based on the microbiome. A pioneer in microbiome mapping technology, Kanvas Biosciences, announced a US$ 12 million Pre-Series A funding round in June 2023. The company's proprietary platform technology, which has the potential to transform drug development for illnesses linked to the microbiome, will be further developed with the help of the investment. These partnerships make sharing resources, know-how, and technological advancements easier, speeding up product development. For instance, a new collaboration was announced between the world's largest food and beverage company, Nestle, and a top-tier SFI research center, APC Microbiome Ireland, in July 2023. The collaboration centers on different aspects of the human microbiome and helps develop new products to enhance human health and wellness. As many as 120 companies are reportedly investing in microbiome analysis, and numerous startups are entering this field. Flagship Pioneering, Seventure Partners, and BioGaia are the most active investors. Thus, increase in investments by key players is likely drive the growth of market.

The comparative company analysis evaluates and categorizes the human microbiome market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global human microbiome market. The key market players are MaaT Pharma; Ferring Holdings SA; Finch Therapeutics Group Inc; AOBiome Therapeutics Inc.; Seres Therapeutics Inc; Merck & Co Inc; Yakult Honsha Co., Ltd; Rebiotix; Inc; IFF Nutrition & Biosciences; and Synthetic Biologics, Inc.

The human microbiome market, based on type, is segmented into product and software and services. The product segment held a larger share of the human microbiome market in 2023, and it is expected to register a higher CAGR during 2023-2031. The human microbiome includes all microorganisms in and on the human body. These microbes have potential for use in disease management. Microbiome products show promise in treating severe conditions and personalizing therapy. The microbiota has been linked to neurological diseases, inflammatory diseases, and cancer.

Based on application, the market is segmented into therapeutics, diagnostics, and research. The therapeutics segment accounted for the largest share of the human microbiome market in 2023. The significant metabolic potential of gut microbes and their role in maintaining human health is emerging, with new possibilities to utilize them as therapeutic agents for addressing human disorders. In recent years, microbiome-based therapeutics, also known as microbiome modulators, have made rapid advances. Several promising candidates have moved forward through the clinical pipeline. For instance, in April 2023, Ferring Pharmaceuticals' VOWST, the first fecal microbiota product taken orally, was approved for preventing recurrence of Clostridioides difficile (C. difficile) infection in patients 18 years and older, following antibiotic treatment for recurrent infection.

Based on disease type, the human microbiome market is segmented into obesity, diabetes, autoimmune disorders, cancer, GIT disorders, and others. The GIT disorders segment held the largest share of the human microbiome market in 2023.

Various organic and inorganic strategies are adopted by companies operating in the human microbiome market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the human microbiome market are listed below.

In March 2024, MaaT Pharma announced the launch of a retrospective multicenter trial called CHRONOS in Europe. Its objective is to provide the Company efficacy data for 3rd-line therapies for patients not receiving MaaT013 or any microbiome intervention. This study was not requested by regulatory authorities and does not impact cash projections as funding has already been secured.

In July 2021, Seres Therapeutics, Inc. and Nestle Health Science entered into commercialization license agreement to jointly commercialize SER-109, Seres' investigational oral microbiome therapeutic for recurrent Clostridioides difficile infection (CDI), in the United States (U.S.) and Canada.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Human Microbiome Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Human Microbiome Market - Key Market Dynamics

  • 5.1 Human Microbiome Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Significant Investments by Key Market Players
    • 5.2.2 Government Initiatives
  • 5.3 Market Restraints
    • 5.3.1 Challenges During Commercialization
  • 5.4 Market Opportunities
    • 5.4.1 Robust Investment in Research and Development
  • 5.5 Future Trends
    • 5.5.1 Emergence of Precision Medicine
  • 5.6 Impact of Drivers and Restraints:

6. Human Microbiome Market - Global Market Analysis

  • 6.1 Human Microbiome Market Revenue (US$ Million), 2021-2031
  • 6.2 Human Microbiome Market Forecast Analysis

7. Human Microbiome Market Analysis - by Type

  • 7.1 Product
    • 7.1.1 Overview
    • 7.1.2 Product: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Software and Services
    • 7.2.1 Overview
    • 7.2.2 Software and Services: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)

8. Human Microbiome Market Analysis - by Application

  • 8.1 Therapeutics
    • 8.1.1 Overview
    • 8.1.2 Therapeutics: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Diagnostics
    • 8.2.1 Overview
    • 8.2.2 Diagnostics: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Research
    • 8.3.1 Overview
    • 8.3.2 Research: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)

9. Human Microbiome Market Analysis - by Disease Type

  • 9.1 Obesity
    • 9.1.1 Overview
    • 9.1.2 Obesity: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Diabetes
    • 9.2.1 Overview
    • 9.2.2 Diabetes: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Autoimmune Disorder
    • 9.3.1 Overview
    • 9.3.2 Autoimmune Disorder: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Cancer
    • 9.4.1 Overview
    • 9.4.2 Cancer: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 GIT
    • 9.5.1 Overview
    • 9.5.2 GIT: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)

10. Human Microbiome Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America Human Microbiome Market Overview
    • 10.2.2 North America: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.2.3 North America: Human Microbiome Market Breakdown, by Type
      • 10.2.3.1 North America: Human Microbiome Market - Revenue and Forecast Analysis - by Type
    • 10.2.4 North America: Human Microbiome Market Breakdown, by Product
      • 10.2.4.1 North America: Human Microbiome Market - Revenue and Forecast Analysis - by Product
    • 10.2.5 North America: Human Microbiome Market Breakdown, by Application
      • 10.2.5.1 North America: Human Microbiome Market - Revenue and Forecast Analysis - by Application
    • 10.2.6 North America: Human Microbiome Market Breakdown, by Disease Type
      • 10.2.6.1 North America: Human Microbiome Market - Revenue and Forecast Analysis - by Disease Type
    • 10.2.7 North America: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.2.7.1 North America: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.2.7.2 United States: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.7.2.1 United States: Human Microbiome Market Breakdown, by Type
        • 10.2.7.2.2 United States: Human Microbiome Market Breakdown, by Product
        • 10.2.7.2.3 United States: Human Microbiome Market Breakdown, by Application
        • 10.2.7.2.4 United States: Human Microbiome Market Breakdown, by Disease Type
      • 10.2.7.3 Canada: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.7.3.1 Canada: Human Microbiome Market Breakdown, by Type
        • 10.2.7.3.2 Canada: Human Microbiome Market Breakdown, by Product
        • 10.2.7.3.3 Canada: Human Microbiome Market Breakdown, by Application
        • 10.2.7.3.4 Canada: Human Microbiome Market Breakdown, by Disease Type
      • 10.2.7.4 Mexico: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.7.4.1 Mexico: Human Microbiome Market Breakdown, by Type
        • 10.2.7.4.2 Mexico: Human Microbiome Market Breakdown, by Product
        • 10.2.7.4.3 Mexico: Human Microbiome Market Breakdown, by Application
        • 10.2.7.4.4 Mexico: Human Microbiome Market Breakdown, by Disease Type
  • 10.3 Europe
    • 10.3.1 Europe Human Microbiome Market Overview
    • 10.3.2 Europe: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.3.3 Europe: Human Microbiome Market Breakdown, by Type
      • 10.3.3.1 Europe: Human Microbiome Market - Revenue and Forecast Analysis - by Type
    • 10.3.4 Europe: Human Microbiome Market Breakdown, by Product
      • 10.3.4.1 Europe: Human Microbiome Market - Revenue and Forecast Analysis - by Product
    • 10.3.5 Europe: Human Microbiome Market Breakdown, by Application
      • 10.3.5.1 Europe: Human Microbiome Market - Revenue and Forecast Analysis - by Application
    • 10.3.6 Europe: Human Microbiome Market Breakdown, by Disease Type
      • 10.3.6.1 Europe: Human Microbiome Market - Revenue and Forecast Analysis - by Disease Type
    • 10.3.7 Europe: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.3.7.1 Europe: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.3.7.2 United Kingdom: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.7.2.1 United Kingdom: Human Microbiome Market Breakdown, by Type
        • 10.3.7.2.2 United Kingdom: Human Microbiome Market Breakdown, by Product
        • 10.3.7.2.3 United Kingdom: Human Microbiome Market Breakdown, by Application
        • 10.3.7.2.4 United Kingdom: Human Microbiome Market Breakdown, by Disease Type
      • 10.3.7.3 Germany: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.7.3.1 Germany: Human Microbiome Market Breakdown, by Type
        • 10.3.7.3.2 Germany: Human Microbiome Market Breakdown, by Product
        • 10.3.7.3.3 Germany: Human Microbiome Market Breakdown, by Application
        • 10.3.7.3.4 Germany: Human Microbiome Market Breakdown, by Disease Type
      • 10.3.7.4 France: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.7.4.1 France: Human Microbiome Market Breakdown, by Type
        • 10.3.7.4.2 France: Human Microbiome Market Breakdown, by Product
        • 10.3.7.4.3 France: Human Microbiome Market Breakdown, by Application
        • 10.3.7.4.4 France: Human Microbiome Market Breakdown, by Disease Type
      • 10.3.7.5 Italy: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.7.5.1 Italy: Human Microbiome Market Breakdown, by Type
        • 10.3.7.5.2 Italy: Human Microbiome Market Breakdown, by Product
        • 10.3.7.5.3 Italy: Human Microbiome Market Breakdown, by Application
        • 10.3.7.5.4 Italy: Human Microbiome Market Breakdown, by Disease Type
      • 10.3.7.6 Spain: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.7.6.1 Spain: Human Microbiome Market Breakdown, by Type
        • 10.3.7.6.2 Spain: Human Microbiome Market Breakdown, by Product
        • 10.3.7.6.3 Spain: Human Microbiome Market Breakdown, by Application
        • 10.3.7.6.4 Spain: Human Microbiome Market Breakdown, by Disease Type
      • 10.3.7.7 Rest of Europe: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.7.7.1 Rest of Europe: Human Microbiome Market Breakdown, by Type
        • 10.3.7.7.2 Rest of Europe: Human Microbiome Market Breakdown, by Product
        • 10.3.7.7.3 Rest of Europe: Human Microbiome Market Breakdown, by Application
        • 10.3.7.7.4 Rest of Europe: Human Microbiome Market Breakdown, by Disease Type
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Human Microbiome Market Overview
    • 10.4.2 Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.4.3 Asia Pacific: Human Microbiome Market Breakdown, by Type
      • 10.4.3.1 Asia Pacific: Human Microbiome Market - Revenue and Forecast Analysis - by Type
    • 10.4.4 Asia Pacific: Human Microbiome Market Breakdown, by Product
      • 10.4.4.1 Asia Pacific: Human Microbiome Market - Revenue and Forecast Analysis - by Product
    • 10.4.5 Asia Pacific: Human Microbiome Market Breakdown, by Application
      • 10.4.5.1 Asia Pacific: Human Microbiome Market - Revenue and Forecast Analysis - by Application
    • 10.4.6 Asia Pacific: Human Microbiome Market Breakdown, by Disease Type
      • 10.4.6.1 Asia Pacific: Human Microbiome Market - Revenue and Forecast Analysis - by Disease Type
    • 10.4.7 Asia Pacific: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.4.7.1 Asia Pacific: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.4.7.2 China: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.7.2.1 China: Human Microbiome Market Breakdown, by Type
        • 10.4.7.2.2 China: Human Microbiome Market Breakdown, by Product
        • 10.4.7.2.3 China: Human Microbiome Market Breakdown, by Application
        • 10.4.7.2.4 China: Human Microbiome Market Breakdown, by Disease Type
      • 10.4.7.3 Japan: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.7.3.1 Japan: Human Microbiome Market Breakdown, by Type
        • 10.4.7.3.2 Japan: Human Microbiome Market Breakdown, by Product
        • 10.4.7.3.3 Japan: Human Microbiome Market Breakdown, by Application
        • 10.4.7.3.4 Japan: Human Microbiome Market Breakdown, by Disease Type
      • 10.4.7.4 India: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.7.4.1 India: Human Microbiome Market Breakdown, by Type
        • 10.4.7.4.2 India: Human Microbiome Market Breakdown, by Product
        • 10.4.7.4.3 India: Human Microbiome Market Breakdown, by Application
        • 10.4.7.4.4 India: Human Microbiome Market Breakdown, by Disease Type
      • 10.4.7.5 Australia: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.7.5.1 Australia: Human Microbiome Market Breakdown, by Type
        • 10.4.7.5.2 Australia: Human Microbiome Market Breakdown, by Product
        • 10.4.7.5.3 Australia: Human Microbiome Market Breakdown, by Application
        • 10.4.7.5.4 Australia: Human Microbiome Market Breakdown, by Disease Type
      • 10.4.7.6 South Korea: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.7.6.1 South Korea: Human Microbiome Market Breakdown, by Type
        • 10.4.7.6.2 South Korea: Human Microbiome Market Breakdown, by Product
        • 10.4.7.6.3 South Korea: Human Microbiome Market Breakdown, by Application
        • 10.4.7.6.4 South Korea: Human Microbiome Market Breakdown, by Disease Type
      • 10.4.7.7 Rest of APAC: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.7.7.1 Rest of APAC: Human Microbiome Market Breakdown, by Type
        • 10.4.7.7.2 Rest of APAC: Human Microbiome Market Breakdown, by Product
        • 10.4.7.7.3 Rest of APAC: Human Microbiome Market Breakdown, by Application
        • 10.4.7.7.4 Rest of APAC: Human Microbiome Market Breakdown, by Disease Type
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa Human Microbiome Market Overview
    • 10.5.2 Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.5.3 Middle East and Africa: Human Microbiome Market Breakdown, by Type
      • 10.5.3.1 Middle East and Africa: Human Microbiome Market - Revenue and Forecast Analysis - by Type
    • 10.5.4 Middle East and Africa: Human Microbiome Market Breakdown, by Product
      • 10.5.4.1 Middle East and Africa: Human Microbiome Market - Revenue and Forecast Analysis - by Product
    • 10.5.5 Middle East and Africa: Human Microbiome Market Breakdown, by Application
      • 10.5.5.1 Middle East and Africa: Human Microbiome Market - Revenue and Forecast Analysis - by Application
    • 10.5.6 Middle East and Africa: Human Microbiome Market Breakdown, by Disease Type
      • 10.5.6.1 Middle East and Africa: Human Microbiome Market - Revenue and Forecast Analysis - by Disease Type
    • 10.5.7 Middle East and Africa: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.5.7.1 Middle East and Africa: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.5.7.2 South Africa: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.7.2.1 South Africa: Human Microbiome Market Breakdown, by Type
        • 10.5.7.2.2 South Africa: Human Microbiome Market Breakdown, by Product
        • 10.5.7.2.3 South Africa: Human Microbiome Market Breakdown, by Application
        • 10.5.7.2.4 South Africa: Human Microbiome Market Breakdown, by Disease Type
      • 10.5.7.3 Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.7.3.1 Saudi Arabia: Human Microbiome Market Breakdown, by Type
        • 10.5.7.3.2 Saudi Arabia: Human Microbiome Market Breakdown, by Product
        • 10.5.7.3.3 Saudi Arabia: Human Microbiome Market Breakdown, by Application
        • 10.5.7.3.4 Saudi Arabia: Human Microbiome Market Breakdown, by Disease Type
      • 10.5.7.4 United Arab Emirates: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.7.4.1 United Arab Emirates: Human Microbiome Market Breakdown, by Type
        • 10.5.7.4.2 United Arab Emirates: Human Microbiome Market Breakdown, by Product
        • 10.5.7.4.3 United Arab Emirates: Human Microbiome Market Breakdown, by Application
        • 10.5.7.4.4 United Arab Emirates: Human Microbiome Market Breakdown, by Disease Type
      • 10.5.7.5 Rest of Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.7.5.1 Rest of Middle East and Africa: Human Microbiome Market Breakdown, by Type
        • 10.5.7.5.2 Rest of Middle East and Africa: Human Microbiome Market Breakdown, by Product
        • 10.5.7.5.3 Rest of Middle East and Africa: Human Microbiome Market Breakdown, by Application
        • 10.5.7.5.4 Rest of Middle East and Africa: Human Microbiome Market Breakdown, by Disease Type
  • 10.6 South and Central America
    • 10.6.1 South and Central America Human Microbiome Market Overview
    • 10.6.2 South and Central America: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.6.3 South and Central America: Human Microbiome Market Breakdown, by Type
      • 10.6.3.1 South and Central America: Human Microbiome Market - Revenue and Forecast Analysis - by Type
    • 10.6.4 South and Central America: Human Microbiome Market Breakdown, by Product
      • 10.6.4.1 South and Central America: Human Microbiome Market - Revenue and Forecast Analysis - by Product
    • 10.6.5 South and Central America: Human Microbiome Market Breakdown, by Application
      • 10.6.5.1 South and Central America: Human Microbiome Market - Revenue and Forecast Analysis - by Application
    • 10.6.6 South and Central America: Human Microbiome Market Breakdown, by Disease Type
      • 10.6.6.1 South and Central America: Human Microbiome Market - Revenue and Forecast Analysis - by Disease Type
    • 10.6.7 South and Central America: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.6.7.1 South and Central America: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.6.7.2 Brazil: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.7.2.1 Brazil: Human Microbiome Market Breakdown, by Type
        • 10.6.7.2.2 Brazil: Human Microbiome Market Breakdown, by Product
        • 10.6.7.2.3 Brazil: Human Microbiome Market Breakdown, by Application
        • 10.6.7.2.4 Brazil: Human Microbiome Market Breakdown, by Disease Type
      • 10.6.7.3 Argentina: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.7.3.1 Argentina: Human Microbiome Market Breakdown, by Type
        • 10.6.7.3.2 Argentina: Human Microbiome Market Breakdown, by Product
        • 10.6.7.3.3 Argentina: Human Microbiome Market Breakdown, by Application
        • 10.6.7.3.4 Argentina: Human Microbiome Market Breakdown, by Disease Type
      • 10.6.7.4 Rest of South and Central America: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.7.4.1 Rest of South and Central America: Human Microbiome Market Breakdown, by Type
        • 10.6.7.4.2 Rest of South and Central America: Human Microbiome Market Breakdown, by Product
        • 10.6.7.4.3 Rest of South and Central America: Human Microbiome Market Breakdown, by Application
        • 10.6.7.4.4 Rest of South and Central America: Human Microbiome Market Breakdown, by Disease Type

11. Competitive Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Human Microbiome Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 MaaT Pharma
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Ferring Holdings SA
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 AOBiome Therapeutics Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Finch Therapeutics Group Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Financial Overview
    • 12.4.4 SWOT Analysis
    • 12.4.5 Key Developments
  • 12.5 Seres Therapeutics Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Merck & Co Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Yakult Honsha Co., Ltd.
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Rebiotix, Inc.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 IFF Nutrition & Biosciences
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Synthetic Biologics, Inc.
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 Glossary of Terms
  • 13.2 About The Insight Partners

List Of Tables

  • Table 1. Human Microbiome Market Segmentation
  • Table 2. Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 4. Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 5. Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 6. Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Type
  • Table 7. North America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 8. North America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 9. North America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. North America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 11. North America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 12. United States: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 13. United States: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 14. United States: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 15. United States: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 16. Canada: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 17. Canada: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 18. Canada: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 19. Canada: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 20. Mexico: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 21. Mexico: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 22. Mexico: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 23. Mexico: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 24. Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 25. Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 26. Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 27. Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 28. Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 29. United Kingdom: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 30. United Kingdom: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 31. United Kingdom: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 32. United Kingdom: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 33. Germany: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 34. Germany: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 35. Germany: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 36. Germany: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 37. France: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 38. France: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 39. France: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 40. France: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 41. Italy: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 42. Italy: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 43. Italy: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 44. Italy: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 45. ADULT OBESITY, 2030
  • Table 46. CHILD OBESITY, 2030
  • Table 47. Spain: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 48. Spain: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 49. Spain: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 50. Spain: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 51. Rest of Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 52. Rest of Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 53. Rest of Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 54. Rest of Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 55. Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 56. Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 57. Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 58. Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 59. Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 60. China: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 61. China: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 62. China: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 63. China: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 64. Japan: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 65. Japan: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 66. Japan: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 67. Japan: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 68. India: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 69. India: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 70. India: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 71. India: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 72. Australia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 73. Australia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 74. Australia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 75. Australia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 76. South Korea: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 77. South Korea: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 78. South Korea: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 79. South Korea: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 80. Rest of APAC: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 81. Rest of APAC: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 82. Rest of APAC: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 83. Rest of APAC: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 84. Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 85. Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 86. Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 87. Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 88. Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 89. South Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 90. South Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 91. South Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 92. South Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 93. Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 94. Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 95. Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 96. Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 97. United Arab Emirates: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 98. United Arab Emirates: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 99. United Arab Emirates: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 100. United Arab Emirates: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 101. Rest of Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 102. Rest of Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 103. Rest of Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 104. Rest of Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 105. South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 106. South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 107. South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 108. South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 109. South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 110. Brazil: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 111. Brazil: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 112. Brazil: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 113. Brazil: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 114. Argentina: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 115. Argentina: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 116. Argentina: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 117. Argentina: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 118. Rest of South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 119. Rest of South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 120. Rest of South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 121. Rest of South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 122. Recent Organic Growth Strategies in the Human Microbiome Market
  • Table 123. Recent Inorganic Growth Strategies in the Human Microbiome Market
  • Table 124. Glossary of Terms, Microelectrode Array in Vitro Market

List Of Figures

  • Figure 1. Human Microbiome Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Human Microbiome Market Revenue (US$ Million), 2021-2031
  • Figure 5. Human Microbiome Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Product: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Software and Services: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Human Microbiome Market Share (%) - by Application (2023 and 2031)
  • Figure 9. Therapeutics: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Diagnostics: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Research: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Human Microbiome Market Share (%) - by Disease Type (2023 and 2031)
  • Figure 13. Obesity: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Diabetes: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Autoimmune Disorder: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Cancer: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. GIT: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Others: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Human Microbiome Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 20. North America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 21. North America: Human Microbiome Market Breakdown, by Type (2023 and 2031)
  • Figure 22. North America: Human Microbiome Market Breakdown, by Product (2023 and 2031)
  • Figure 23. North America: Human Microbiome Market Breakdown, by Application (2023 and 2031)
  • Figure 24. North America: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
  • Figure 25. North America: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 26. United States: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 27. Canada: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 28. Mexico: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 29. Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. Europe: Human Microbiome Market Breakdown, by Type (2023 and 2031)
  • Figure 31. Europe: Human Microbiome Market Breakdown, by Product (2023 and 2031)
  • Figure 32. Europe: Human Microbiome Market Breakdown, by Application (2023 and 2031)
  • Figure 33. Europe: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
  • Figure 34. Europe: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 35. United Kingdom: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. Germany: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. France: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. Italy: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 39. Spain: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. Rest of Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. Asia Pacific: Human Microbiome Market Breakdown, by Type (2023 and 2031)
  • Figure 43. Asia Pacific: Human Microbiome Market Breakdown, by Product (2023 and 2031)
  • Figure 44. Asia Pacific: Human Microbiome Market Breakdown, by Application (2023 and 2031)
  • Figure 45. Asia Pacific: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
  • Figure 46. Asia Pacific: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 47. China: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 48. Japan: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 49. India: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 50. Australia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 51. South Korea: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 52. Rest of APAC: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 53. Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 54. Middle East and Africa: Human Microbiome Market Breakdown, by Type (2023 and 2031)
  • Figure 55. Middle East and Africa: Human Microbiome Market Breakdown, by Product (2023 and 2031)
  • Figure 56. Middle East and Africa: Human Microbiome Market Breakdown, by Application (2023 and 2031)
  • Figure 57. Middle East and Africa: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
  • Figure 58. Middle East and Africa: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 59. South Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 60. Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 61. United Arab Emirates: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 62. Rest of Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 63. South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 64. South and Central America: Human Microbiome Market Breakdown, by Type (2023 and 2031)
  • Figure 65. South and Central America: Human Microbiome Market Breakdown, by Product (2023 and 2031)
  • Figure 66. South and Central America: Human Microbiome Market Breakdown, by Application (2023 and 2031)
  • Figure 67. South and Central America: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
  • Figure 68. South and Central America: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 69. Brazil: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 70. Argentina: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 71. Rest of South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 72. Growth Strategies in the Human Microbiome Market